Seth M. Steinberg

87.2k citations

864 papers · 58.9k indexed · 13 hit papers · h-index 124

Impact in

Oncology top 0.01%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
Immunology top 0.05%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction

Papers in

Oncology 409
- Cancer Immunotherapy and Biomarkers 73
- Viral-associated cancers and disorders 62
- CAR-T cell therapy research 60
Genetics 98
- Chronic Lymphocytic Leukemia Research 60

Co-authors: Steven A. Rosenberg James Chih‐Hsin Yang Richard M. Sherry Suzanne L. Topalian David J. Liewehr Donald E. White Douglas J. Schwartzentruber William D. Figg
Journals: Journal of Clinical Oncology (166 papers)Blood (82 papers)Clinical Cancer Research (56 papers)Cancer (28 papers)Cancer Research (19 papers)
Partner nations: United States Italy Malaysia

In The Last Decade

Seth M. Steinberg

854 papers receiving 57.3k citations

Hit Papers

13 papers align trajectories log scale

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL 2021 · 200 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Journal of Clinical Oncology
2014 The Lancet
2011 Clinical Cancer Research
2009 Journal of Clinical Oncology
2007 Clinical Cancer Research
2003 New England Journal of Medicine
2003 Journal of Clinical Oncology
2003 Proceedings of the National Academy of Sciences
2002 The Lancet
1998 Journal of Clinical Oncology
1995 New England Journal of Medicine
1995 New England Journal of Medicine
1987 Annals of Surgery

Peers

Countries citing papers authored by Seth M. Steinberg

Since Specialization

Citations

This map shows the geographic impact of Seth M. Steinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth M. Steinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth M. Steinberg more than expected).

Fields of papers citing papers by Seth M. Steinberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth M. Steinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth M. Steinberg. The network helps show where Seth M. Steinberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Seth M. Steinberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Seth M. Steinberg Line = papers co-authored together Seth M. Steinberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers Frontiers in Oncology ·隆広山本, Cody J. Peer, Xianyu Zhang, Hyoyoung Choo‐Wosoba, Yang Wen-Guang, Min-Jung Lee, Shraddha Rastogi, N Sato, Yunkai Yu, В А Охорзин, Seth M. Steinberg, Rüdiger Welker, Liang Cao, William D. Figg, Jane B. Trepel, Ira Pastan, David FitzGerald, Christine Alewine	2024	3
2	Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study Clinical Cancer Research ·Erika J. Lampert, Alexandra S. Zimmer, Michelle R. Padget, Ashley Cimino‐Mathews, Jayakumar R. Nair, Yingmiao Liu, Elizabeth M. Swisher, James W. Hodge, Andrew B. Nixon, E. Hitt Nichols, Mohammadhadi Bagheri, Elliott Levy, Marc R. Radke, Stanley Lipkowitz, Christina M. Annunziata, Janis M. Taube, Seth M. Steinberg, Jung‐Min Lee	2020	150
3	Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas Clinical Cancer Research ·Nurainun Adamy, John Glod, 小西健介, Miki Kasai, Joanne Derdak, Eva Dombi, Alphonse Kwawisi Tekpetey, Daniel W. Beury, Melinda S. Merchant, Heejae So, David J. Liewehr, Seth M. Steinberg, Brigitte C. Widemann, Rosandra N. Kaplan	2020	21
4	Alterations in Pericyte Subpopulations Are Associated with Elevated Blood–Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer Clinical Cancer Research ·L. Tiffany Lyle, Paul R. Lockman, Chris E. Adkins, Afroz S. Mohammad, Ricky Norpratama Putra, Emily Hua, Diane Palmieri, David J. Liewehr, Seth M. Steinberg, Wojciech Kloc, Ewa Iżycka‐Świeszewska, Renata Duchnowska, Naema Nayyar, Priscilla K. Brastianos, Patricia S. Steeg, Brunilde Gril	2016	120
5	Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study Journal of Clinical Oncology ·Mark N. Polizzotto, Thomas S. Uldrick, Kathleen M. Wyvill, Karen Aleman, Cody J. Peer, Margaret Bevans, Irini Sereti, Frank Maldarelli, Denise Whitby, Vickie Marshall, Priscila Gonçalves, Vikram Khetani, William D. Figg, Seth M. Steinberg, Jerome B. Zeldis, Robert Yarchoan	2016	86
6	Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease Blood ·Thomas S. Uldrick, Mark N. Polizzotto, Karen Aleman, Kathleen M. Wyvill, Vickie Marshall, Denise Whitby, Victoria Wang, Stefania Pittaluga, Deirdre O’Mahony, Seth M. Steinberg, Richard F. Little, Robert Yarchoan	2014	80
7	A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study Clinical Cancer Research ·Anish Thomas, Arun Rajan, Éva Szabó, Yusuke Tomita, Corey A. Carter, Barbara Scepura, Ariel López-Chávez, Min-Jung Lee, Christophe E. Redon, Gayatri Amirthalingham, Cody J. Peer, Yuanbin Chen, Richard Piekarz, Seth M. Steinberg, Jane B. Trepel, William D. Figg, David S. Schrump, Giuseppe Giaccone	2014	79
8	Profound Prevention of Experimental Brain Metastases of Breast Cancer by Temozolomide in an MGMT-Dependent Manner Clinical Cancer Research ·Diane Palmieri, Renata Duchnowska, Stephan Woditschka, Emily Hua, Yongzhen Qian, Wojciech Biernat, Putri Budi Setyowati, Brunilde Gril, Andreas M. Stark, Stephen M. Hewitt, David J. Liewehr, Seth M. Steinberg, Jacek Jassem, Patricia S. Steeg	2014	45
9	Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer Cancer Immunology Research ·James L. Gulley, Ravi A. Madan, Kwong Y. Tsang, Caroline Jochéms, Jennifer L. Marté, Benedetto Farsaci, Jo A. Tucker, James W. Hodge, David J. Liewehr, Seth M. Steinberg, Christopher R. Heery, Jeffrey Schlom	2013	101
10	Electrocardiographic Studies of Romidepsin Demonstrate Its Safety and Identify a Potential Role for KATP Channel Clinical Cancer Research ·Anne M. Noonan, AHAHA雅文太田, David J. Liewehr, Tristan M. Sissung, David Venzon, Thomas P. Flagg, Mark C. Haigney, Seth M. Steinberg, William D. Figg, Richard Piekarz, Susan E. Bates	2013	39
11	TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells Molecular Cancer Therapeutics ·Daniel P. Fitzgerald, David L. Emerson, Yongzhen Qian, Talha Anwar, David J. Liewehr, Seth M. Steinberg, Sandra Silberman, Diane Palmieri, Patricia S. Steeg	2012	69
12	A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer Clinical Cancer Research ·Mahsa Mohebtash, Kwong-Yok Tsang, Ravi A. Madan, Ngar‐Yee Huen, Diane J. Poole, Caroline Jochéms, Jacquin Jones, Byron Javier Rivera Ochoa, Christopher R. Heery, Philip M. Arlen, Seth M. Steinberg, Mary Pazdur, Myrna Rauckhorst, Elizabeth C. Jones, William L. Dahut, Jeffrey Schlom, James L. Gulley	2011	101
13	Impact of ABCB1 Allelic Variants on QTc Interval Prolongation Clinical Cancer Research ·Tristan M. Sissung, Erin R. Gardner, Richard Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo, Ryan M. Franke, James Clark, Laura Miller‐DeGraff, Seth M. Steinberg, David Venzon, David J. Liewehr, Steven R. Kleeberger, Susan E. Bates, Douglas K. Price, Douglas R. Rosing, Christopher H. Cabell, Alex Sparreboom, William D. Figg	2010	24
14	A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer Clinical Cancer Research ·Ronan J. Kelly, Deborah Draper, Clara C. Chen, Robert W. Robey, William D. Figg, Richard Piekarz, Xiaohong Chen, Erin R. Gardner, Frank M. Balis, Aradhana M. Venkatesan, Seth M. Steinberg, Tito Fojo, Susan E. Bates	2010	151
15	The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma Blood ·Kieron Dunleavy, Richard F. Little, Stefania Pittaluga, Nicole Grant, Alan S. Wayne, Jorge A. Carrasquillo, Seth M. Steinberg, Robert Yarchoan, Elaine S. Jaffe, Wyndham H. Wilson	2010	123
16	Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers Journal of Clinical Oncology ·Wyndham H. Wilson, Kieron Dunleavy, Stefania Pittaluga, Upendra P. Hegde, Nicole Grant, Seth M. Steinberg, Mark Raffeld, Martin Gutierrez, Bruce A. Chabner, Louis M. Staudt, Elaine S. Jaffe, John E. Janik	2008	217
17	Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma Clinical Cancer Research ·James L. Gulley, Philip M. Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Diane J. Poole, Cinzia Remondo, Vittore Cereda, Jacquin Jones, Mary Pazdur, Jack P. Higgins, James W. Hodge, Seth M. Steinberg, Herbert L. Kotz, William L. Dahut, Jeffrey Schlom	2008	176
18	Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer Clinical Cancer Research ·Sherry Yang, Seth M. Steinberg, Dat Nguyen, Thomas D. Wu, Zora Modrušan, Sandra M. Swain	2008	69
19	Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling Clinical Cancer Research ·Ben Davidson, Virginia Espina, Seth M. Steinberg, Viví Ann Flørenes, Lance A. Liotta, Gunnar B. Kristensen, Claes G. Tropé, Aasmund Berner, Elise C. Kohn	2006	62
20	Allogeneic Lymphocytes Induce Tumor Regression of Advanced Metastatic Breast Cancer Journal of Clinical Oncology ·Michael Bishop, Daniel H. Fowler, Dale Elizabeth Pehrsson, Kathleen M. Castro, Claude Kasten-Sportès, Seth M. Steinberg, Juan Gea‐Banacloche, Robert M. Dean, Catherine K. Chow, Charles W. Carter, Elizabeth J. Read, Susan F. Leitman, Ronald E. Gress	2004	74

About Seth M. Steinberg

Seth M. Steinberg is a scholar working on Oncology, Genetics, Pathology and Forensic Medicine, Hematology and Pulmonary and Respiratory Medicine, having authored 864 papers that have together received 58.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (118 papers), Immunotherapy and Immune Responses (79 papers), Cancer Immunotherapy and Biomarkers (73 papers), Viral-associated cancers and disorders (62 papers), Prostate Cancer Treatment and Research (61 papers), Chronic Lymphocytic Leukemia Research (60 papers), CAR-T cell therapy research (60 papers) and Hematopoietic Stem Cell Transplantation (51 papers). The work is most often cited by research in Oncology (29.1k citations), Immunology (12.8k citations), Cancer Research (7.9k citations), Pathology and Forensic Medicine (8.1k citations) and Pulmonary and Respiratory Medicine (13.6k citations). Seth M. Steinberg has collaborated with scholars based in United States, Italy and Malaysia. Frequent co-authors include Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, David J. Liewehr, Donald E. White, Douglas J. Schwartzentruber, William D. Figg, Elise C. Kohn and Elaine S. Jaffe. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact